Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1896 Cr | ₹8114 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.14 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | 1.42% | 0.96% |
| 6 Month | 8.56% | 3.75% |
| 1 Year | 5.92% | -0.65% |
| 3 Year | - | 20.63% |
| 5 Year | - | 17.65% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | 2.42% | 0.38% |
| 1 Year | 12.14% | 5.17% |
| 3 Year | - | 17.57% |
| 5 Year | - | 16.53% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 27.59% | 16.99% |
| 3 Year | - | 20.8% |
| 5 Year | - | 20.54% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 15.24% |
| Sharp | - | 0.90% |
| Beta | - | 0.91% |
| Alpha | - | -0.55% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 7.7 | 1.52 |
| Mid Cap | 30.89 | 33.86 |
| Small Cap | 35.06 | 31.35 |
| Large Cap | 26.35 | 33.27 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.03 | 0.53 |
| Basic Materials | 2.31 | - |
| Healthcare | 96.66 | 99.47 |
Top Comparisons
Nippon India Large Cap Fund- Growth Plan Bonus Option
3Y Returns%
Axis Large Cap Fund - Regular Plan - Growth
3Y Returns11.14%
PGIM India Corporate Bond Fund - Growth
3Y Returns7.31%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns7.41%
ICICI Prudential Dividend Yield Equity Fund Growth Option
3Y Returns22.78%
SBI Dividend Yield Fund - Regular Plan - Growth
3Y Returns0%
Franklin India Aggressive Hybrid Fund - Growth Plan
3Y Returns14.23%
HDFC Hybrid Equity Fund - Growth Plan
3Y Returns12.04%